IRDye800CW-BBN

IRDye800CW-BBN conjugate imaging agent

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IRDye800CW-BBN, covering 2024-08-06 to 2024-08-06. Get the full timeline:

Most recent: Clinical Trial Update: IRDye800CW-BBN PET-NIRF Imaging Guiding Surgery in Patients With Lower Grade Glioma [Phase 1]